This session will explore anaphylaxis is a potentially life-threatening complication of treatment for cancer and other disorders. Presentation and manifestations can vary by systems involved and severity. We will discuss the pathophysiology of anaphylaxis and emergency management of this often rapidly progressing complication. We will address the differences and similarities between infusion reactions, cytokine release syndrome, and anaphylaxis, and how to recognize these reactions. We will explore titer monitoring and desensitization protocols for asparaginase and further nursing implications for administering high risk medications.
This contains 2 sections:
Understand the immune response that leads to anaphylaxis.
Understand common triggers of anaphylaxis in the Hematology/ Oncology population.
Understand the role of Hematology/ Oncology nurses in the responses and treatment of anaphylaxis.
APHON will provide .5 nursing continuing professional development (NCPD) contact hour(s) for the successful completion of this session. Successful completion requires attendance for the entire session and completion of the post-session evaluation.
The Association for Pediatric Hematology Oncology Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This provider is also approved by the California Board of Registered Nursing, Provider Number 14513.
None of the planners for this activity have relevant financial relationship(s) to disclose with ineligible companies.
This program content has been reviewed by the Oncology Nursing Certification Corporation (ONCC) and is acceptable for recertification points. You may claim 1 ILNA in one of the following categories:
Questions or concerns? Contact education@aphon.org.